skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Eprenetapopt (APR-246) and Azacitidine in TP53 -Mutant Myelodysplastic Syndromes
Eprenetapopt (APR-246) and Azacitidine in TP53 -Mutant Myelodysplastic Syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Eprenetapopt (APR-246) and Azacitidine in TP53 -Mutant Myelodysplastic Syndromes

Sallman, David A ; DeZern, Amy E ; Garcia-Manero, Guillermo ; Steensma, David P ; Roboz, Gail J ; Sekeres, Mikkael A ; Cluzeau, Thomas ; Sweet, Kendra L ; McLemore, Amy ; McGraw, Kathy L ; Puskas, John ; Zhang, Ling ; Yao, Jiqiang ; Mo, Qianxing ; Nardelli, Lisa ; Al Ali, Najla H ; Padron, Eric ; Korbel, Greg ; Attar, Eyal C ; Kantarjian, Hagop M ; Lancet, Jeffrey E ; Fenaux, Pierre ; List, Alan F ; Komrokji, Rami S

Journal of clinical oncology, 2021-05, Vol.39 (14), p.1584-1594 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
2
Eprenetapopt Plus Azacitidine in TP53 -Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)
Eprenetapopt Plus Azacitidine in TP53 -Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Eprenetapopt Plus Azacitidine in TP53 -Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)

Cluzeau, Thomas ; Sebert, Marie ; Rahmé, Ramy ; Cuzzubbo, Stefania ; Lehmann-Che, Jacqueline ; Madelaine, Isabelle ; Peterlin, Pierre ; Bève, Blandine ; Attalah, Habiba ; Chermat, Fatiha ; Miekoutima, Elsa ; Rauzy, Odile Beyne ; Recher, Christian ; Stamatoullas, Aspasia ; Willems, Lise ; Raffoux, Emmanuel ; Berthon, Céline ; Quesnel, Bruno ; Loschi, Michael ; Carpentier, Antoine F ; Sallman, David A ; Komrokji, Rami ; Walter-Petrich, Anouk ; Chevret, Sylvie ; Ades, Lionel ; Fenaux, Pierre

Journal of clinical oncology, 2021-05, Vol.39 (14), p.1575-1583 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
3
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Material Type:
Artigo 		Adicionar ao Meu Espaço

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

Lipson, David A ; Barnhart, Frank ; Brealey, Noushin ; Brooks, Jean ; Criner, Gerard J ; Day, Nicola C ; Dransfield, Mark T ; Halpin, David M.G ; Han, MeiLan K ; Jones, C. Elaine ; Kilbride, Sally ; Lange, Peter ; Lomas, David A ; Martinez, Fernando J ; Singh, Dave ; Tabberer, Maggie ; Wise, Robert A ; Pascoe, Steven J

The New England journal of medicine, 2018-05, Vol.378 (18), p.1671-1680 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
4
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial

Lee, Laurie A ; Bailes, Zelie ; Barnes, Neil ; Boulet, Louis-Philippe ; Edwards, Dawn ; Fowler, Andrew ; Hanania, Nicola A ; Kerstjens, Huib A M ; Kerwin, Edward ; Nathan, Robert ; Oppenheimer, John ; Papi, Alberto ; Pascoe, Steven ; Brusselle, Guy ; Peachey, Guy ; Sule, Neal ; Tabberer, Maggie ; Pavord, Ian D

The lancet respiratory medicine, 2021-01, Vol.9 (1), p.69-84 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Aapro, M. ; Rugo, H. ; Rossi, G. ; Rizzi, G. ; Borroni, M.E. ; Bondarenko, I. ; Sarosiek, T. ; Oprean, C. ; Cardona-Huerta, S. ; Lorusso, V. ; Karthaus, M. ; Schwartzberg, L. ; Grunberg, S.

Annals of oncology, 2014-07, Vol.25 (7), p.1328-1333 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

BASCH, Ethan ; PRESTRUD, Ann Alexis ; MORROW, Gary ; RAO, Kamakshi V ; SCHWARTZ, Rowena N ; LYMAN, Gary H ; HESKETH, Paul J ; KRIS, Mark G ; FEYER, Petra C ; SOMERFIELD, Mark R ; CHESNEY, Maurice ; CLARK-SNOW, Rebecca Anne ; FLAHERTY, Anne Marie ; FREUNDLICH, Barbara

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4189-4198 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study

Hesketh, P.J. ; Rossi, G. ; Rizzi, G. ; Palmas, M. ; Alyasova, A. ; Bondarenko, I. ; Lisyanskaya, A. ; Gralla, R.J.

Annals of oncology, 2014-07, Vol.25 (7), p.1340-1346 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD

Donohue, J.F ; Maleki-Yazdi, M.R ; Kilbride, S ; Mehta, R ; Kalberg, C ; Church, A

Respiratory medicine, 2013-10, Vol.107 (10), p.1538-1546 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy

Gralla, R.J. ; Bosnjak, S.M. ; Hontsa, A. ; Balser, C. ; Rizzi, G. ; Rossi, G. ; Borroni, M.E. ; Jordan, K.

Annals of oncology, 2014-07, Vol.25 (7), p.1333-1339 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Material Type:
Artigo 		Adicionar ao Meu Espaço

Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

Shirley, Matt

Drugs (New York, N.Y.), 2021-07, Vol.81 (11), p.1331-1342 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (504)

Idioma 

  1. Inglês  (506)
  2. Japonês  (109)
  3. Russo  (9)
  4. Alemão  (6)
  5. Italiano  (2)
  6. Chinês  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.